Skip to main content
. 2017 Jul 11;9:495–514. doi: 10.2147/BCTT.S139963

Table 2.

Representative recent trials in metastatic HR+ breast cancer

Intervention Months survival Trial
Anastrozole + fulvestrant 48 SWOG
Anastrozole + fulvestrant 38 FACT
Anastrozole + fulvestrant 21 SoFEA
Letrozole + fulvestrant 52 LEA
Everolimus + exemestane 31 BOLERO 2